CHEK2 1100delC in patients with metachronous cancers of the breast and the colorectum
Main Authors: | Isinger, Anna, Bhat, Misha, Borg, Ake, Nilbert, Mef |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2006
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1421428/ |
Similar Items
-
Genomic profiling of CHEK2*1100delC-mutated breast carcinomas
by: Massink, Maarten P. G., et al.
Published: (2015) -
CHEK2
∗1100delC Mutation and Risk of Prostate Cancer
by: Hale, Victoria, et al.
Published: (2014) -
Breast tumors from CHEK2 1100delC-mutation carriers: genomic landscape and clinical implications
by: Muranen, Taru A, et al.
Published: (2011) -
Survival and contralateral breast cancer in CHEK2 1100delC breast cancer patients: impact of adjuvant chemotherapy
by: Kriege, M, et al.
Published: (2014) -
CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population
by: Sanna Hallamies, et al.
Published: (2017-09-01)